Unnamed: 0,title,date,stock,sentiment
472366.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-06-10 07:35:00-04:00,EYES,neutral
472367.0,90 Biggest Movers From Yesterday,2020-06-10 05:46:00-04:00,EYES,neutral
472368.0,64 Stocks Moving In Tuesday's Mid-Day Session,2020-06-09 12:26:00-04:00,EYES,neutral
472369.0,34 Stocks Moving in Tuesday's Pre-Market Session,2020-06-09 07:11:00-04:00,EYES,neutral
472370.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,EYES,negative
472371.0,Second Sight Medical 13G Filing From Altium Capital Shows New 9.5% Stake,2020-05-08 12:10:00-04:00,EYES,neutral
472372.0,Second Sight Medical Products Announces The Closing Of Common Stock Offering Of 7.5 Million Shares At $1 Per Share,2020-05-05 13:09:00-04:00,EYES,positive
472373.0,Second Sight Medical 13G Filing From Empery Asset Mgmt. Shows New 9.51% Stake,2020-05-05 09:27:00-04:00,EYES,positive
472374.0,98 Biggest Movers From Friday,2020-05-04 05:08:00-04:00,EYES,neutral
472375.0,58 Stocks Moving In Friday's Mid-Day Session,2020-05-01 12:39:00-04:00,EYES,neutral
472376.0,"The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO",2020-05-01 07:54:00-04:00,EYES,neutral
472377.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-01 07:42:00-04:00,EYES,neutral
472378.0,32 Stocks Moving in Friday's Pre-Market Session,2020-05-01 07:15:00-04:00,EYES,neutral
472379.0,Second Sight Medical Products Prices 7.5M Share Public Offering of Common Stock @$1.00/Share,2020-05-01 05:42:00-04:00,EYES,positive
472380.0,72 Biggest Movers From Yesterday,2020-05-01 05:29:00-04:00,EYES,neutral
472381.0,16 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-04-29 07:35:00-04:00,EYES,neutral
472382.0,"Second Sight Medical Outlines Steps To Cut Overhead, Conserve Liquidity",2020-04-28 08:03:00-04:00,EYES,negative
472383.0,"UPDATE: Nasdaq Notice Of Non Compliance To Second Sight Relates To Co. Naming Matthew Pfeffer Acting CEO, Separation Of Patrick Ryan As Co.'s COO",2020-04-21 16:35:00-04:00,EYES,neutral
472384.0,"Second Sight Medical 8-K Shows Co. Received Letter From Nasdaq Stating Co. No Long In Compliance With Independent Director, Audit Committee Requirements",2020-04-21 16:34:00-04:00,EYES,negative
472385.0,"Second Sight Medical Shares Spike To Session High, Up 13%; Traders Circulate Apr. 21-Dated USPTO Abstract For 'Visual prosthetic apparatus for retinal stimulation'",2020-04-21 10:46:00-04:00,EYES,positive
472386.0,"The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation",2020-04-07 07:55:00-04:00,EYES,negative
472387.0,"The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests",2020-04-01 07:38:00-04:00,EYES,neutral
472388.0,77 Biggest Movers From Yesterday,2020-04-01 04:31:00-04:00,EYES,neutral
472389.0,56 Stocks Moving In Tuesday's Mid-Day Session,2020-03-31 12:27:00-04:00,EYES,neutral
472390.0,"The Daily Biotech Pulse: Amarin Faces Legal Setback, Milestone Payment Kicks In For CytomX, Savara, Reata Disclose COVID-19 Disruptions",2020-03-31 08:26:00-04:00,EYES,negative
472391.0,17 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-03-31 07:58:00-04:00,EYES,neutral
472392.0,40 Stocks Moving in Tuesday's Pre-Market Session,2020-03-31 07:51:00-04:00,EYES,neutral
472393.0,80 Biggest Movers From Yesterday,2020-03-31 04:15:00-04:00,EYES,neutral
472394.0,"Second Sight Medical Shares Resume Trade, Fall To Session Low, Down 25% For Session",2020-03-30 13:48:00-04:00,EYES,neutral
472395.0,"Second Sight Medical Names Chair Of Audit Committee, Matthew Pfeffer, Acting CEO; Chair Gregg Williams Will Not Oversee Co. Through Transitional Wind Down",2020-03-30 13:25:00-04:00,EYES,neutral
472396.0,"Second Sight Medical Reports, Following Evaluation Of Strategic Alternatives And Inability To Secure Added Funding, Will Pursue Orderly Wind Down Of Operations",2020-03-30 13:24:00-04:00,EYES,negative
472397.0,"Second Sight Medical ProductsSays- Will Lay Off Approximately 84 of Its 108 Employees Effective March 31, 2020",2020-03-30 13:16:00-04:00,EYES,positive
472398.0,Second Sight Medical Shares Halted News Pending,2020-03-30 12:58:00-04:00,EYES,positive
472399.0,"Second Sight Medical Q4 EPS $(0.47) Beats $(0.49) Estimate, Sales $497K Beat $470K Estimate",2020-03-19 16:06:00-04:00,EYES,neutral
472400.0,"Second Sight Reports Pres, CEO Will McGuire To Depart; Names Gregg Williams Acting CEO",2020-03-12 16:34:00-04:00,EYES,neutral
472401.0,140 Biggest Movers From Yesterday,2020-02-28 05:00:00-05:00,EYES,neutral
472402.0,80 Biggest Movers From Yesterday,2020-02-11 04:44:00-05:00,EYES,neutral
472403.0,Second Sight Medical Granted US Patent Titled 'Aggregate electrode for neural stimulation',2020-02-04 10:39:00-05:00,EYES,positive
472404.0,85 Biggest Movers From Yesterday,2020-02-04 04:56:00-05:00,EYES,neutral
472405.0,82 Biggest Movers From Friday,2020-02-03 05:00:00-05:00,EYES,neutral
472406.0,25 Medical Devices Stocks Moving In Tuesday's Session,2020-01-28 12:48:00-05:00,EYES,neutral
472407.0,"The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study",2020-01-24 07:43:00-05:00,EYES,negative
472408.0,52 Biggest Movers From Yesterday,2020-01-24 04:40:00-05:00,EYES,neutral
472409.0,36 Stocks Moving In Thursday's Mid-Day Session,2020-01-23 14:05:00-05:00,EYES,neutral
472410.0,23 Medical Devices Stocks Moving In Thursday's Session,2020-01-23 12:58:00-05:00,EYES,neutral
472411.0,"The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment",2020-01-23 07:24:00-05:00,EYES,positive
472412.0,27 Medical Devices Stocks Moving In Tuesday's Session,2020-01-21 14:36:00-05:00,EYES,neutral
472413.0,"The Daily Biotech Pulse: Verastem In-Licenses Chughai's Tumor Drug, Midatech Surges On Positive Study Results",2020-01-08 08:12:00-05:00,EYES,positive
472414.0,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering",2020-01-07 07:57:00-05:00,EYES,negative
472415.0,"Second Sight Medical 8-K Shows Second Amendment To Restated Articles To Effect 1-For-8 Reverse Stock Split, Effective Jan. 6, 2020",2020-01-03 06:10:00-05:00,EYES,positive
472416.0,"Dougherty & Co. Initiates Coverage On Second Sight Medical with Buy Rating, Announces $2 Price Target",2019-12-13 10:26:00-05:00,EYES,neutral
472417.0,"Second Sight Medical Q3 EPS $(0.06), Inline",2019-11-14 16:08:00-05:00,EYES,neutral
472418.0,Second Sight Medical Products Shares Spike As Traders Circulate Earlier CBS News Feature On The Company,2019-09-18 10:42:00-04:00,EYES,positive
472419.0,"Second Sight Medical Q2 EPS $(0.07) Misses $(0.06) Estimate, Sales $1.282M Beat $450K Estimate",2019-08-06 16:31:00-04:00,EYES,negative
472420.0,"UPDATE: Second Sight Says Results On Primary, Secondary Endpoints Have Been 'Positive'",2019-06-25 17:11:00-04:00,EYES,neutral
472421.0,Second Sight Medical Earlier After-Hours Press Release Highlighted Presentation Of 12-Month Results From Early Feasibility Study Of Orion At World Society for Stereotactic and Functional Neurosurgery Meeting,2019-06-25 17:10:00-04:00,EYES,neutral
472422.0,Second Sight Medical Products shares are trading higher despite Q1 results which missed analyst estimates.,2019-05-15 17:33:00-04:00,EYES,neutral
472423.0,"Second Sight Medical Q1 EPS $(0.07) Misses $(0.06) Estimate, Sales $1.128M Miss $1.66M Estimate",2019-05-15 17:32:00-04:00,EYES,negative
472424.0,"Earnings Scheduled For May 15, 2019",2019-05-15 04:33:00-04:00,EYES,neutral
472425.0,Second Sight Highlights Presentation Of Updated Interim Results For Early Feasibility Study Of Orion Visual Cortical Prosthesis System At BRAIN Initiative,2019-04-11 08:07:00-04:00,EYES,neutral
472426.0,71 Biggest Movers From Yesterday,2019-03-15 05:24:00-04:00,EYES,neutral
472427.0,56 Stocks Moving In Thursday's Mid-Day Session,2019-03-14 12:24:00-04:00,EYES,neutral
472428.0,35 Stocks Moving In Thursday's Pre-Market Session,2019-03-14 08:07:00-04:00,EYES,neutral
472429.0,Second Sight Medical Products shares are trading lower after the company reported lower-than-expected Q4 sales results.,2019-03-13 17:00:00-04:00,EYES,neutral
472430.0,"Second Sight Medical Q4 EPS $(0.10) Beats $(0.11) Estimate, Sales $1.767M Miss $2.64M Estimate",2019-03-13 16:40:00-04:00,EYES,negative
472431.0,Second Sight Reports $40M Rights Offering,2019-01-07 08:11:00-05:00,EYES,neutral
472432.0,Second Sight Sees FY18 Sales $6.5M-$6.9M vs $7.76M Est.,2019-01-07 08:10:00-05:00,EYES,neutral
472433.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018",2018-12-20 11:33:00-05:00,EYES,negative
472434.0,"Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018",2018-12-14 11:03:00-05:00,EYES,negative
472435.0,Second Sight Completes $3M Private Placement With Chair Gregg Williams,2018-12-14 08:14:00-05:00,EYES,neutral
472436.0,"The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch",2018-12-14 07:47:00-05:00,EYES,neutral
472437.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Dec. 3, 2018",2018-12-04 09:21:00-05:00,EYES,negative
472438.0,"Stocks Which Set New 52-Week Low The Prior Trading Session, Fri., Nov. 23, 2018",2018-11-26 10:44:00-05:00,EYES,negative
472439.0,"Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018",2018-11-23 09:09:00-05:00,EYES,negative
472440.0,"Second Sight Medical Q3 EPS $(0.12) Beats $(0.14) Estimate, Sales $2.246M Miss $2.48M Estimate",2018-11-07 16:48:00-05:00,EYES,negative
472441.0,"Second Sight Medical Products Director Gregg Williams Buys 2,467,767 @ Avg Price: $1.62",2018-10-22 19:56:00-04:00,EYES,neutral
472442.0,"Second Sight Medical Announces Completion of $4M Private Placement with Gregg Williams, Chairman of the Board",2018-10-22 09:04:00-04:00,EYES,neutral
472443.0,UPDATE: Second Sight Medical Sees Recognizing ~$600K Pre-Tax Restructuring Charges In Q4,2018-10-10 17:21:00-04:00,EYES,negative
472444.0,"Second Sight Medical 8-K Shows Co. Implemented Restructuring Plan Which Will Result In Reduced Expenses, Personnel By 8 Employees",2018-10-10 17:21:00-04:00,EYES,neutral
472445.0,Second Sight Receives $1.6M Grant from National Institutes of Health to Support Orion Clinical Development,2018-09-18 08:03:00-04:00,EYES,positive
472446.0,Second Sight Names Pat Ryan COO,2018-09-04 08:15:00-04:00,EYES,neutral
472447.0,"Second Sight Medical Q2 EPS $(0.12), Same YoY, Sales $1.907M Beat $976K Estimate",2018-08-07 17:12:00-04:00,EYES,neutral
472448.0,"Second Sight Medical Products Director Gregg Williams Buys 25,575 @ Avg Price: $1.78",2018-07-19 04:28:00-04:00,EYES,neutral
472449.0,"Second Sight Medical Products Director Gregg Williams Buys 43,843 @ Avg Price: $1.92",2018-06-06 20:20:00-04:00,EYES,neutral
472450.0,"B. Riley Investor Conference Concludes Today With Presenters Including: SeviceSource, Second Sight Medical, Universal Electronics, Inseego, and Tyler Technologies",2018-05-24 08:40:00-04:00,EYES,neutral
472451.0,"Second Sight Medical Q1 EPS $(0.14) Up From $(0.16) YoY, Sales $976K Down From $1.009M YoY",2018-05-10 16:31:00-04:00,EYES,neutral
472452.0,"UPDATE: Second Sight Shares Down ~$0.15 Following Circulation of Cliffside Research Rating, Now Down 1.7% For The Day",2018-05-09 11:54:00-04:00,EYES,positive
472453.0,"Cliffside Research Out With Strong Sell Rating On Second Sight Medical, Gives Co. A $0.24 Price Target",2018-05-09 11:53:00-04:00,EYES,positive
472454.0,Second Sight Medical Products Announces a $10M Private Placement with the Chairman of the Board,2018-05-07 08:20:00-04:00,EYES,neutral
472455.0,Second Sight Names John Blake CFO,2018-03-22 08:03:00-04:00,EYES,neutral
472456.0,Second Sight Names Gregg Williams Chair,2018-03-16 08:01:00-04:00,EYES,neutral
472457.0,"Second Sight Medical Shares Down 6.5% For Session, Down 17% From Pre-Market Highs Despite Q4 Sales Beat And Better-Than-Expected Loss",2018-03-08 12:15:00-05:00,EYES,neutral
472458.0,"Second Sight Medical Shares Up 15% After Hours Following Better-Than-Expected Q4 Loss, Strong Sales",2018-03-07 16:36:00-05:00,EYES,positive
472459.0,"Second Sight Medical Products Reports Q4 Adj. EPS $(0.14) vs $(0.17) In Same Qtr. Last Year, Sales $3.1M vs $715K YoY",2018-03-07 16:07:00-05:00,EYES,neutral
472460.0,Second Sight Medical Shares Up ~$0.15 Over Last Few Mins. As Traders Circulate FDA Voice Blog Post 'Brain Implant for Some Blind People Shows Benefits of FDA's Breakthrough Device Program',2018-02-27 12:52:00-05:00,EYES,positive
472461.0,Second Sight Medical Reports First PatientImplanted With Argus II System In Singapore,2018-02-16 08:22:00-05:00,EYES,neutral
472462.0,40 Biggest Movers From Yesterday,2018-02-07 05:09:00-05:00,EYES,neutral
472463.0,30 Stocks Moving In Tuesday's Mid-Day Session,2018-02-06 12:06:00-05:00,EYES,neutral
472464.0,33 Biggest Movers From Yesterday,2018-02-06 05:09:00-05:00,EYES,neutral
472465.0,Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; Crude Oil Down 2%,2018-02-05 14:30:00-05:00,EYES,negative
472466.0,31 Stocks Moving In Monday's Mid-Day Session,2018-02-05 12:43:00-05:00,EYES,neutral
472467.0,Mid-Day Market Update: Dow Falls Over 250 Points; Enphase Energy Shares Spike Higher,2018-02-05 12:21:00-05:00,EYES,positive
472468.0,Second Sight Reports That It Implanted 30 Argus II Retinal Prosthesis Systems In Q4,2018-02-05 08:14:00-05:00,EYES,neutral
472469.0,"Second Sight Shares Spike 5% Higher Mid-Day, Now Over $2 Level; Volume Also Spiked As Price Moved; Not Seeing News To Justify Price Action, But $2 Was A Notable Resistance Level Previously",2018-01-04 12:17:00-05:00,EYES,positive
472470.0,32 Biggest Movers From Yesterday,2017-12-15 05:43:00-05:00,EYES,neutral
472471.0,32 Stocks Moving In Thursday's Mid-Day Session,2017-12-14 12:44:00-05:00,EYES,neutral
472472.0,40 Biggest Movers From Yesterday,2017-12-13 05:08:00-05:00,EYES,neutral
472473.0,Second Sight Option Alert: Jul 20 $2.5 Calls Sweep (13) at the Bid: 922 @ $0.35 vs 352 OI; Ref=$1.999,2017-12-11 15:31:00-05:00,EYES,positive
472474.0,Second Sight Reports Market Entry into Iran with First 2 Implants of Argus II Retinal Prosthesis System,2017-12-05 09:02:00-05:00,EYES,neutral
472475.0,Ontario Health Technology Advisory Committee Recommends Public Funding for Second Sight's Argus II Retinal Prosthesis System,2017-11-10 08:00:00-05:00,EYES,positive
472476.0,Second Sight Reports Received FDA Expedited Access Pathway Designation For Orion Cortical Visual Prosthesis System,2017-11-08 08:00:00-05:00,EYES,neutral
472477.0,16 Stocks Moving In Thursday's After-Hours Session,2017-11-02 17:36:00-04:00,EYES,neutral
472478.0,"Second Sight Reports Q3 EPS $(0.12) vs $(0.20) In Prior Year Period, Sales $1.61M vs $1.18M In Prior Year Period",2017-11-02 16:00:00-04:00,EYES,neutral
472479.0,Second Sight Reports Received Full FDA Approval To Begin First Orion Human Study,2017-11-02 08:24:00-04:00,EYES,positive
472480.0,Second Sight Reports Final Medicare Hospital Outpatient Payment Rate for 2018 for the Argus II Retinal Prosthesis System,2017-11-02 08:03:00-04:00,EYES,neutral
472481.0,Second Sight Files for Up to $100M Mixed Shelf,2017-10-31 06:10:00-04:00,EYES,neutral
472482.0,Second Sight Approval Receives Approval In Germany To Begin Study To Implant And Evaluate Argus II In Better-Sighted Retinitis Pigmentosa Patients,2017-10-17 07:02:00-04:00,EYES,positive
472483.0,"Second Sight Medical Shares Volatile Higher, Tick To Session Highs As Traders Circulate MIT Tech Review Article Featuring Co. 'Blind Patients to Test Bionic Eye Brain Implants'",2017-09-18 14:20:00-04:00,EYES,negative
472484.0,13D Filing From Gregg Williams On Second Sight Medical Shows 41.64% Stake,2017-09-11 15:18:00-04:00,EYES,neutral
472485.0,18 Biggest Mid-Day Gainers For Monday,2017-08-28 12:35:00-04:00,EYES,neutral
472486.0,25 Stocks Moving In Monday's Pre-Market Session,2017-08-28 08:16:00-04:00,EYES,neutral
472487.0,Second Sight Receives Conditional FDA Approval to Start First Orion Human Clinical Study,2017-08-28 08:00:00-04:00,EYES,positive
472488.0,"Second Sight Medical Products Reports Q2 Adj. Loss/Share $(0.12) vs. $(0.15) Est., Sales $2.2M vs. $1.43M Est.",2017-08-01 17:15:00-04:00,EYES,neutral
472489.0,Second Sight Medical Products Submitted an Application for an Investigational Device Exemption with the FDA to Conduct an Early Feasibility Study of Orion in a Clinical Trial of up to 5 Patients,2017-07-18 06:16:00-04:00,EYES,neutral
472490.0,Second Sight Reports Market Entry into South Korea with Two Implants,2017-07-05 08:06:00-04:00,EYES,neutral
472491.0,10 Biggest Mid-Day Gainers For Monday,2017-07-03 12:21:00-04:00,EYES,neutral
472492.0,"Second Sight Reports Expansion Of Medicare Coverage For Argus II Retinal Prosthesis System To 11 Added States, District Of Columbia",2017-07-03 08:08:00-04:00,EYES,neutral
472493.0,Second Sight Medical CFO Resigns to Pursue Other Opportunities,2017-06-26 06:09:00-04:00,EYES,positive
472494.0,"B. Riley Investor Conference Concludes Today, Presenters Include: Six Flags, BSquare, TrueCar, Meet Group, Second Sight Medical, Resonant, Ooma, And Monotype Imaging",2017-05-25 08:24:00-04:00,EYES,neutral
472495.0,Second Sight Medical Products Releases Investor Presentation,2017-05-25 06:11:00-04:00,EYES,neutral
472496.0,"Second Sight Medical Reports Q1 Adj. EPS $(0.16) vs $(0.14) Est., Sales $1M vs $1.32M Est.",2017-05-03 16:45:00-04:00,EYES,neutral
472497.0,Second Sight Spikes to High of $1.30 on Volume,2017-05-02 12:58:00-04:00,EYES,neutral
472498.0,Second Sight +16% Premarket @$1.35 Following Announcement Argus II Retinal Prosthesis Implanted in First Patient in Asia,2017-04-13 07:15:00-04:00,EYES,neutral
472499.0,Second Sight Medical Reports Argus II Retinal Prosthesis Implanted in First Patient in Asia,2017-04-13 07:03:00-04:00,EYES,neutral
472500.0,Second Sight Spikes to High of $1.31; Large Insider Buy Reported Late Monday,2017-04-11 10:09:00-04:00,EYES,neutral
472501.0,"Second Sight Medical Products (Director, 10%+ Owner) Gregg Williams Buys 4,216,705 Shares @ Avg Price: $0.95 (Form4)",2017-04-11 04:18:00-04:00,EYES,positive
472502.0,Shares of Second Sight at Low of $1.17; Earlier Chatter Mentioned Possible BCBS Coverage of Argus II; Coverage May be Part of BCBS Product 'Evidence Street',2017-04-04 12:27:00-04:00,EYES,neutral
472503.0,"Second Sight Medical Announces Warrants To Be Listed On Nasdaq, Ticker EYESW",2017-03-27 16:32:00-04:00,EYES,neutral
472504.0,15 Biggest Mid-Day Losers For Wednesday,2017-03-22 13:02:00-04:00,EYES,negative
472505.0,15 Biggest Mid-Day Losers For Friday,2017-03-10 13:04:00-05:00,EYES,negative
472506.0,"Second Sight Reports Q4 Adj. EPS $(0.17) vs. $(0.17) Est., Sales $715K vs. $1.76M Est.",2017-03-09 16:01:00-05:00,EYES,neutral
472507.0,Second Sight Pops to High of $1.52 Following Earlier Volume Spike,2017-03-07 13:47:00-05:00,EYES,neutral
472508.0,20 Biggest Mid-Day Losers For Wednesday,2017-02-08 13:09:00-05:00,EYES,negative
472509.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-02-08 08:28:00-05:00,EYES,neutral
472510.0,Second Sight Reports Positive Reimbursement Renewal Decision in Germany,2017-02-02 08:06:00-05:00,EYES,positive
472511.0,Second Sight Medical Announces Rights Offering,2017-01-09 08:24:00-05:00,EYES,neutral
472512.0,15 Biggest Mid-Day Gainers For Thursday,2016-12-22 12:35:00-05:00,EYES,neutral
472513.0,Second Sight Announces Support from UK Government for Argus II,2016-12-22 06:05:00-05:00,EYES,positive
472514.0,"UK Government Announces Funding for Second Sight's Argus II ""Bionic Eye""",2016-12-22 06:04:00-05:00,EYES,neutral
472515.0,22 Stocks Moving In Thursday's Pre-Market Session,2016-12-01 08:30:00-05:00,EYES,neutral
472516.0,Man Receives Vision-restoring Retinal Implant at University of Illinois at Chicago,2016-11-17 12:48:00-05:00,EYES,neutral
472517.0,Second Sight Shares Spiking Higher,2016-11-17 12:46:00-05:00,EYES,positive
472518.0,Second Sight Spikes to High of $2.48 on Volume,2016-11-17 12:46:00-05:00,EYES,neutral
472519.0,"Second Sight Reports Q3 EPS $(0.44) vs. Est. $(0.16), Rev. $1.2M vs. Est. $2.36M",2016-11-02 16:40:00-04:00,EYES,neutral
472520.0,Second Sight Reports CMS Finalizes its Medicare Hospital Outpatient Payment Rate For $150K For Cost Of Argus II Retinal Prosthesis System,2016-11-02 07:08:00-04:00,EYES,neutral
472521.0,Mid-Afternoon Market Update: Crane Rises On Upbeat Earnings; Dipexium Shares Fall,2016-10-25 15:22:00-04:00,EYES,positive
472522.0,15 Biggest Mid-Day Gainers For Tuesday,2016-10-25 12:47:00-04:00,EYES,neutral
472523.0,Here's Why You're Seeing Movement In Second Sight Medical,2016-10-25 10:36:00-04:00,EYES,neutral
472524.0,Second Sight Announces Successful Implantation and Activation of Wireless Visual Cortical Stimulator in First Human Subject,2016-10-25 08:04:00-04:00,EYES,positive
472525.0,"UPDATE: Second Sight Medical Shares Spike Into Positive Territory, Now Up ~1%",2016-08-22 12:24:00-04:00,EYES,positive
472526.0,Traders Attribute Spike in Second Sight to Article in National Geographic Mentioning Argus II,2016-08-22 12:22:00-04:00,EYES,neutral
472527.0,Here Are All The CEOs Benzinga Spoke With In 2016,2016-08-16 11:30:00-04:00,EYES,neutral
472528.0,Second Sight Announces Two Exclusive Distribution Agreements to Bring the Argus II Retinal Prosthesis to Taiwan and Iran,2016-07-28 16:19:00-04:00,EYES,positive
472529.0,"Second Sight Medical Products Reports Q2 EPS $(0.23) Vs Est $(0.15), Sales $1.0M Vs Est $1.38M",2016-07-28 16:12:00-04:00,EYES,neutral
472530.0,UPDATE: Second Sight PR Regarding Positive 5-Year Data From Argus II System Was Previously Posted July 21st at 4:05pm ET,2016-07-25 15:07:00-04:00,EYES,positive
472531.0,Second Sight Spikes to High on Vol,2016-07-25 14:59:00-04:00,EYES,neutral
472532.0,Second Sight Announces Positive Five-Year Data from Argus II Retinal Prosthesis System,2016-07-25 14:59:00-04:00,EYES,positive
472533.0,12 Biggest Mid-Day Gainers For Friday,2016-07-22 12:50:00-04:00,EYES,neutral
472534.0,15 Stocks Moving In Friday's Pre-Market Session,2016-07-22 08:30:00-04:00,EYES,neutral
472535.0,Second Sight Reports Positive Five-Year Data from Argus II Retinal Prosthesis System,2016-07-21 16:26:00-04:00,EYES,positive
472536.0,Technical Alert: Second Sight Med Products Trims Gains,2016-07-07 14:06:00-04:00,EYES,positive
472537.0,Second Sight Announces CMS Establishes Proposed Medicare Outpatient Rate for Argus II of $150K,2016-07-07 06:06:00-04:00,EYES,neutral
472538.0,Shares of SecondSight Medical Up ~$0.40 Over Last Few Mins as Traders Passing Around Article from Optometry Today 'WORLD FIRST FOR STARGARDT'S DISEASE',2016-07-06 10:04:00-04:00,EYES,positive
472539.0,"Second Sight Moving On Fox News Article, Implant Gives Blind Ohio Man His Sight Back",2016-06-09 13:17:00-04:00,EYES,negative
472540.0,Second Sight Spikes to High of $4.10 on Vol; Traders Attributing to Fox News Report,2016-06-09 13:16:00-04:00,EYES,neutral
472541.0,Second Sight Shares Spiking,2016-06-09 13:15:00-04:00,EYES,positive
472542.0,Bionic eye restores man's vision after being blind for 40 years -BGR,2016-05-18 10:17:00-04:00,EYES,positive
472543.0,UPDATE: Each Right Will Entitle Holder to Invest $0.55 for Each Share of Second Sight Common Stock Owned as of Record Date,2016-05-09 17:38:00-04:00,EYES,positive
472544.0,"Second Sight Files S-1 Registration Statement for Rights Offering to Shareholders, Sets Record Date",2016-05-09 17:37:00-04:00,EYES,neutral
472545.0,"Second Sight Reports Q1 EPS $(0.16) vs. Est. $(0.16), Rev. $1.1M vs. Est. $1.38M",2016-04-28 16:01:00-04:00,EYES,neutral
472546.0,Second Sight Medical Products Files to Sell Up to 10M Shares of Common Stock S-1A,2016-04-22 06:56:00-04:00,EYES,positive
472547.0,"UPDATE: Second Sight Says Public Consultation Allows Stakeholders Including Would-be, Previously Implanted Argus II Patients, Doctors, Blindness Charities the Opportunity to Comment on New Draft Policy to Fund Treatment through NHS England",2016-04-06 04:46:00-04:00,EYES,positive
472548.0,Second Sight Says NHS England Issues Public Policy Consultation on UK Government Funding of the Argus® II Bionic Eye,2016-04-06 04:43:00-04:00,EYES,neutral
472549.0,"Rodman & Renshaw Maintains Buy on Second Sight Medical, Lowers PT to $16.00",2016-03-04 07:05:00-05:00,EYES,negative
472550.0,"Second Sight Reports Q4 EPS $(0.13) vs. Est. $(0.14), Rev. $2.4M vs. Est. $2.47M",2016-03-03 16:01:00-05:00,EYES,neutral
472551.0,MannKind Founder Alfred Mann Dies at 90,2016-02-26 05:22:00-05:00,EYES,neutral
472552.0,Second Sight Shares Sell Off to Low of $5.90 on Volume,2016-02-25 09:53:00-05:00,EYES,neutral
472553.0,"UPDATE: Coverage of the Argus II Implantation Procedure for Medicare Patients in Florida, Puerto Rico, U.S. Virgin Islands has been Enabled",2016-02-25 08:22:00-05:00,EYES,neutral
472554.0,"Medicare Administrative Contractor for Florida, Puerto Rico, U.S. Virgin Islands Removes CPT 0100T from Noncovered Services Local Coverage Determination List",2016-02-25 08:20:00-05:00,EYES,positive
472555.0,"Streetsweeper Goes Negative On Second Sight, Says These Risks Are 'Eye-Opening'",2016-02-24 13:51:00-05:00,EYES,negative
472556.0,"UPDATE: StreetSweeper Says Second Sight ""needs to push out a potentially dilutive stock offering""",2016-02-24 12:02:00-05:00,EYES,neutral
472557.0,TheStreetSweeper issues a brand-new alert on Second Sight Medical Products,2016-02-24 12:00:00-05:00,EYES,positive
472558.0,EXCLUSIVE: Second Sight Chairman Dishes On Recent Success As Shares Skyrocket,2016-02-23 11:37:00-05:00,EYES,positive
472559.0,"EXLUSIVE: HC Wainwright's Dayal Says Despite His Bullish View On The Unique Story, Company Needs To Increase Implants & Commercialization",2016-02-23 11:13:00-05:00,EYES,positive
472560.0,"EXCLUSIVE: HC Wainwright's Amit Dayal Says Second Sight Is ""Only name in town for these type of procedures, everyone else is 2-3 years behind"".",2016-02-23 11:11:00-05:00,EYES,positive
472561.0,"EXCLUSIVE: Second Sight's Dr. Greenberg Says Sell-Side Coverage Have Shown Increased Interest In Second Sight, Has Spoken With Many Sell-Side Analysts",2016-02-23 11:07:00-05:00,EYES,positive
472562.0,"EXCLUSIVE: Second Sight's Dr. Greenberg Says Company's Technology Has Potential To Treat Glaucoma, Diabetes, Infection, Trauma; Nearly All Forms Of Blindness, Which Could Open Market to 6 Million Patients Globally",2016-02-23 11:03:00-05:00,EYES,positive
472563.0,"EXCLUSIVE: Dr. Greenberg Says New Glasses Hardware Upgrades Improve Processing Power 25x Volts, Which Improves Vision Enhancement",2016-02-23 10:46:00-05:00,EYES,positive
472564.0,"EXCLUSIVE: Dr. Greenberg Says Guidance From Surgery Turnaround At Centers is 1/month, Sees Higher Turnaround As Surgeons Become More Comfortable With Aftercare",2016-02-23 10:44:00-05:00,EYES,positive
472565.0,"EXCLUSIVE: Dr. Greenberg Says Second Sight Wants To Increase Surgery Centers, But Have Not Set An Exact Number That They Would Like To Open This Year",2016-02-23 10:41:00-05:00,EYES,positive
472566.0,"EXCLUSIVE: Second Sight's Dr. Greenberg ""Feels pretty good about our supply chain capabilities right now""",2016-02-23 10:39:00-05:00,EYES,positive
472567.0,"EXCLUSIVE: Second Sight's Dr. Greenberg Says They Are Currently Creating 100 Argus II Products/Year, Thinks They Can 1,000/Year At Current Facility Before Needing To Move",2016-02-23 10:38:00-05:00,EYES,positive
472568.0,EXCLUSIVE: Dr. Greenberg Says Planned Growth Going Forward Is In Regions That Have Planned Coverage And Availability Of Centers Where Patients Can Reasonably Travel To,2016-02-23 10:36:00-05:00,EYES,positive
472569.0,"EXCLUSIVE: Second Sight Chairman Dr. Robert Greenberg Says Focus Of The HBO Vice Special Was To Inform Other Patients Of This Life Saving Therapy, Has No Comment On Stock Move",2016-02-23 10:33:00-05:00,EYES,positive
472570.0,"Earlier 8-K from Second Sight Showed Slideshow for '16 Investor Presentation; Showed $21.7M in Cash as of Sept. 30, 2015 with No Debt",2016-02-23 08:24:00-05:00,EYES,negative
472571.0,"UPDATE: Second Sight Says Study Results from Argus II Trial Program Will Be Presented at Annual Macula Society Meeting Feb. 24-27, 2016",2016-02-23 08:21:00-05:00,EYES,neutral
472572.0,Second Sight to Announce Five-Year Data from Argus II Clinical Trial Program,2016-02-23 08:12:00-05:00,EYES,neutral
472573.0,Investors Look Into Second Sight Medical Products Inc After HBO Feature Is Announced,2016-02-22 13:51:00-05:00,EYES,neutral
472574.0,Second Sight Pops 15%; HBO's 'Vice' To Run Segment On 'Beating Blindness',2016-02-22 11:19:00-05:00,EYES,negative
472575.0,"Second Sight Spokesperson Confirms Approved Language, Copy Draft for 'Vice' Episode on 'Beating Blindness' Mentions Co.'s Argus II Product; However Co. Still Awaiting Final Release from HBO",2016-02-22 11:15:00-05:00,EYES,negative
472576.0,UPDATE: Second Sight Medical Shares Up ~12% as Co. Says Will Be Featured on HBO's Vice This Week,2016-02-22 10:47:00-05:00,EYES,positive
472577.0,"Second Sight Homepage Shows Co. 'to be Featured on HBO's VICE Episode - ""Beating Blindness"" on Feb 26th at 8pm PST'",2016-02-22 10:23:00-05:00,EYES,negative
472578.0,Second Sight Medical Spikes to High of $4.86 on Volume,2016-01-26 10:17:00-05:00,EYES,neutral
472579.0,Second Sight Medical Issues Press Release Announcing Filing of S-1 Registration for Rights Offering to Holders,2016-01-25 17:24:00-05:00,EYES,neutral
472580.0,Second Sight Finds Support And Rebounds,2015-12-29 14:31:00-05:00,EYES,positive
472581.0,Second Sight Medical +12.5%; May be Attributed to Unconfirmed Takeover Chatter,2015-12-16 10:25:00-05:00,EYES,negative
472582.0,Second Sight Medical +8%; May be Attributed to Denver Post Article on Bionic Eye Transplant,2015-12-10 11:09:00-05:00,EYES,neutral
472583.0,Second Sight Medical Spikes Higher,2015-12-04 14:22:00-05:00,EYES,neutral
472584.0,"Second Sight Reports Q3 EPS $(0.10) vs. Est. $(0.14), Rev. $2.2M vs. Est. $2.05M",2015-10-29 16:20:00-04:00,EYES,neutral
472585.0,Second Sight Reports Q2 EPS $(0.24) vs. Prior Year Quarter $(0.40),2015-08-04 16:13:00-04:00,EYES,neutral
472586.0,"Second Sight Names Will McGuire President, CEO",2015-08-04 16:11:00-04:00,EYES,neutral
472587.0,"H.C. Wainwright Reiterates Buy On Second Sight Medical, Believes 'Significant' Growth Is Coming",2015-07-22 13:57:00-04:00,EYES,positive
472589.0,Second Sight Announces First Age-Related Macular Degeneration Patient Receives Argus II Retinal Prosthesis System,2015-07-22 05:01:00-04:00,EYES,neutral
472590.0,Second Sight Announces Expansion of Argus II Availability in Europe,2015-07-15 08:02:00-04:00,EYES,neutral
472591.0,Benzinga's Top Initiations,2015-07-06 09:57:00-04:00,EYES,positive
472592.0,"Rodman & Renshaw Initiates Coverage on Second Sight Medical at Buy, Announces $21.00 PT",2015-07-06 07:25:00-04:00,EYES,neutral
472593.0,"H.C. Wainwright Initiates Coverage on Second Sight Medical at Buy, Announces $21.00 PT",2015-07-06 07:11:00-04:00,EYES,neutral
472594.0,Second Sight Appoints Will McGuire As CEO & President,2015-06-25 07:05:00-04:00,EYES,neutral
472595.0,Second Sight Medical Just Had Another Big Day...And More Headlines Could Be Coming,2015-06-23 17:01:00-04:00,EYES,neutral
472596.0,"Tuesday's Mid-Day Movers: Ambarella Retaliates; Sonic, BlackBerry Hit",2015-06-23 11:51:00-04:00,EYES,neutral
472597.0,Benzinga's Volume Movers,2015-06-23 10:33:00-04:00,EYES,neutral
472598.0,Second Sight Shares +14% Premarket Following Announcement of Positive Long-Term Results of the Argus II Retinal Prosthesis System,2015-06-23 08:55:00-04:00,EYES,positive
472599.0,Second Sight Announces Positive Long-Term Results of the Argus II Retinal Prosthesis System,2015-06-23 08:31:00-04:00,EYES,positive
472600.0,Second Sight Shares +6%; Presenting at JMP Securities Life Sciences Conference Wednesday June 24 at 1:00 PM ET,2015-06-22 09:49:00-04:00,EYES,positive
472601.0,Second Sight Shares +7.5%; May be Attributed to Note by Louis Basenese,2015-05-29 09:55:00-04:00,EYES,positive
472602.0,UPDATE: 60 Minutes Australia Filming Second Sight Segment,2015-05-14 14:14:00-04:00,EYES,neutral
472603.0,Second Sight Medical Tweet Indicates '60 Minutes' Appearance,2015-05-14 14:11:00-04:00,EYES,neutral
472604.0,Second Sight Shares Rise Following Q1 Results,2015-05-13 17:36:00-04:00,EYES,positive
472605.0,"Second Sight Reports Q1 EPS $(0.14), Rev. $1.7M; Estimates Not Available",2015-05-13 16:04:00-04:00,EYES,neutral
472606.0,Second Sight Medical Products Shares Spike Higher; May be Attributed to Seeking Alpha Post,2015-04-14 10:54:00-04:00,EYES,positive
472607.0,Morning Market Gainers,2015-04-08 09:40:00-04:00,EYES,neutral
472608.0,Second Sight Announces First Successful Implant of Model of Orion I Visual Cortical Prosthesis,2015-04-08 08:04:00-04:00,EYES,positive
472609.0,7 Stocks To Watch On April 1,2015-03-31 19:27:00-04:00,EYES,neutral
472610.0,"Second Sight Medical Jumps, Adds Italy To Its Market",2015-03-05 12:12:00-05:00,EYES,neutral
472611.0,Benzinga's Volume Movers,2015-03-05 10:21:00-05:00,EYES,neutral
472612.0,Morning Market Gainers,2015-03-05 09:41:00-05:00,EYES,neutral
472613.0,Second Sight Announces Successful First Implants of Argus Retinal Prosthesis System at Two New Centers in Italy,2015-03-05 08:23:00-05:00,EYES,positive
472614.0,TheStreetSweeper releases an investigative report on Second Sight Medical Products,2015-03-02 10:10:00-05:00,EYES,neutral
472615.0,9 Stocks Technicians Are Watching Very Closely This Week,2015-03-01 20:09:00-05:00,EYES,neutral
472616.0,9 Trending Stocks From Friday: Second Sight Medical's Huge Gain Leads Pack,2015-02-27 18:33:00-05:00,EYES,positive
472617.0,"Second Sight Shares Sharply Higher, Up 45%",2015-02-27 14:14:00-05:00,EYES,positive
472618.0,Benzinga's Volume Movers,2015-02-27 10:25:00-05:00,EYES,neutral
472619.0,Second Sight's 30% Jump Boosts Several Peers,2015-02-25 13:16:00-05:00,EYES,positive
472620.0,Benzinga's Volume Movers,2015-02-25 10:42:00-05:00,EYES,neutral
472621.0,BiotechBreakthroughs ‏@BioBreakthrough Tweet $RWLK  Former high-flyer will follow $EYES momentum.  Recent story of police officer able to walk again. http://www.kob.com/article/stories/s3712894.shtml#.VOzfSrk5Cpo …,2015-02-24 15:40:00-05:00,EYES,neutral
472622.0,Morning Market Gainers,2015-02-24 09:40:00-05:00,EYES,neutral
472623.0,Update: Second Sight Medical Products Shares Rise 20% Premarket as Co Announces First Commercial Implants of Argus II Retinal Prosthesis System in France,2015-02-24 08:28:00-05:00,EYES,positive
472624.0,Second Sight Receives Highest Priority Reimbursement for Argus II in Germany,2015-02-03 07:11:00-05:00,EYES,neutral
472625.0,Second Sight Medical Products Awarded Patent for Field Focusing and Mapping in Visual Prosthesis,2015-01-13 10:41:00-05:00,EYES,positive
472626.0,Second Sight Medical Products Spikes 10% Following Health Canada Approval,2015-01-12 09:51:00-05:00,EYES,positive
472627.0,Merger Monday Moving Stocks Monday Morning,2015-01-12 09:48:00-05:00,EYES,neutral
472628.0,Health Canada Approves Second Sight's Argus II Retinal Prosthesis System,2015-01-12 08:03:00-05:00,EYES,positive
472629.0,Jim Cramer Advises His Viewers On Wynn Resorts And Second Sight Medical Products,2015-01-06 07:53:00-05:00,EYES,neutral
472630.0,Stocks Hitting 52-Week Lows,2014-12-18 10:10:00-05:00,EYES,negative
472631.0,"Second Sight Announces Underwriter Exercises Entire Over-Allotment Option For 525,000 Shares",2014-11-24 09:22:00-05:00,EYES,positive
472632.0,Second Sight Medical CEO: Gratifying That So Many People Are Interested In What We Do,2014-11-20 12:36:00-05:00,EYES,positive
472633.0,Shares Of Second Sight Medical Continue Showing Strength Following Wednesday's IPO,2014-11-20 10:34:00-05:00,EYES,positive
472634.0,Second Sight Trading Resumes,2014-11-19 12:12:00-05:00,EYES,neutral
472635.0,Second Sight Shares Halted On LULD,2014-11-19 12:09:00-05:00,EYES,positive
472636.0,"Second Sight Medical Opens For trading At $17/Share, IPO Priced At $9/Share",2014-11-19 12:07:00-05:00,EYES,neutral
472637.0,"S-1 from Second Sight Shows Co. Expects to Offer 3.5M Shares at $9/Share in IPO, Will List on NASDAQ Under Symbol 'EYES'",2014-08-12 14:26:00-04:00,EYES,positive
